| Literature DB >> 34337406 |
Abbie E Smith-Ryan1,2, Mark A Weaver3, Anthony J Viera4, Morris Weinberger5, Malia N M Blue1,2, Katie R Hirsch1,2.
Abstract
Physical activity and healthy diet are recognized as effective approaches for disease prevention. Controlled laboratory clinical trials support these approaches, yet minimal data exists supporting implementation of exercise as medicine within a healthcare setting.Entities:
Keywords: cardiovascular health and disease; exercise is medicine; high intensity interval training; lifestyle intervation; pilot and feasibility study
Year: 2021 PMID: 34337406 PMCID: PMC8322607 DOI: 10.3389/fspor.2021.690243
Source DB: PubMed Journal: Front Sports Act Living ISSN: 2624-9367
Patients (n = 10) and Physicians (n = 5) interview questions.
| (1) Previous exercise experience (type of exercise, consistency and recent history of exercise) |
| (2) Preferred structure of an exercise program (mode of exercise, environment, duration, intensity) |
| (3) Preferred delivery of an exercise program (one-on-one, group setting, in-person, videos, etc.) |
| (4) Facilitators and barriers toward participating in exercise |
| Nutrition Related Topics |
| (1) Previous experience with healthy eating |
| (2) Supplementation use |
| (3) Primary source for nutrition information |
| (4) Facilitators and barriers to healthy eating |
| - Current referral/recommendation practices for exercise and nutrition for patients |
| - Common barriers to exercise and healthy lifestyle practices among patients |
| - Opinions on improving adherence and feasibility of prescribing exercise and nutrition as a preventative health strategy |
| - Clinical perspective on the use of higher intensity exercise for their patients |
| - Opinion on nutritional recommendations and meal replacements as a nutritional intervention |
| - Primary source for nutrition information |
Figure 1Meal replacement supplement facts panel.
Figure 2Details of participant recruitment, maintenance, and follow-up.
Details of compliance for paper logs, FitBit and HR chest monitor for tracking exercise.
| Paper Logs | 6/10 | 4/24 |
| 8/24 | ||
| 10/24 | ||
| 21/24 | ||
| 24/24 | ||
| 24/24 | ||
| FitBit | 9/10 | 76.2/84 total days |
| HR Chest Strap | Not tracked automatically; not captured. | |
Change in physiological variables from pre to post-intervention (12-weeks) presented as mean ± SD (n = 10).
| Average Systolic BP (mmHg) | −3.8 ± 8.0 | (−13.0,5.5) | |
| Average Diastolic BP (mmHg) | −1.4 ± 4.6 | (−6.8,3.9) | |
| Body Fat% | |||
| BIS (%) | 0.5 ± 1.0 | (−0.8,1.7) | |
| Ultrasound (%) | 0.3 ± 0.8 | (−0.7,1.3) | |
| Abdominal Fat (cm) | −3.4 ± 14.4 | (−20.0,13.2) | |
| VO2peak (ml·kg·min−1) | 4.8 ± 3.8 | (0.3,9.2) | |
| Total Cholesterol (mg/dL) | 4.1 ± 10.8 | (−8.2,16.4) | |
| Triglycerides (mg/dL) | −5.2 ± 29.6 | (−38.6,28.2) | |
| HDL (mg/dL) | 1.4 ± 3.6 | (−2.7,5.5) | |
| LDL (mg/dL) | 3.7 ± 15.6 | (−14.0,21.4) | |
| Glucose (mg/dL) | −8.0 ± 23.4 | (−34.4,18.4) | |
| Insulin (IU/L) | 0.6 ± 10.0 | (−12.2,11.0) | |
| Hemoglobin A1c (mg/dL) | 5.4 ± 10.2 | (−16.9,6.2) |
indicates significant change.
Figure 3Individual response and mean ± SD data for baseline, 3 months, and 6 months for (A) triglycerides and (B) peak oxygen consumption (VO2peak.).